Palisade Bio, Inc. (PALI)

Palisade Bio Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	4	5	8	18	15	4
Market Cap Growth	-67.85%	-32.16%	-54.57%	15.94%	297.62%	-32.85%
Enterprise Value	-7	-7	-4	7	16	-1
PE Ratio	-	-0.44	-0.55	-0.66	-1.47	-0.46
PS Ratio	-	21.75	-	-	-	248.66
PB Ratio	0.42	0.48	0.64	2.40	-0.92	0.75
P/FCF Ratio	-0.47	-0.49	-0.60	-1.19	-3.19	-0.53
P/OCF Ratio	-0.47	-0.49	-0.60	-1.19	-3.19	-0.53
EV/Sales Ratio	-	-26.60	-	-	-	-56.77
EV/EBITDA Ratio	0.45	0.55	0.28	-0.30	-1.60	0.11
EV/EBIT Ratio	0.45	0.54	0.27	-0.30	-1.58	0.10
EV/FCF Ratio	0.56	0.60	0.30	-0.50	-3.33	0.12
Debt / Equity Ratio	0.02	0.03	0.03	0.03	-0.09	0.08
Debt / EBITDA Ratio	-0.01	-0.03	-0.03	-0.01	-0.14	-0.05
Debt / FCF Ratio	-0.02	-0.03	-0.03	-0.01	-0.30	-0.06
Quick Ratio	4.58	4.82	4.12	4.22	0.10	4.19
Current Ratio	4.87	5.15	4.89	4.61	0.11	4.61
Asset Turnover	0	0.02	0	0	0	0.00
Interest Coverage	-842.94	-820.07	-1118.08	-10.10	-42.92	-935.28
Return on Equity (ROE)	-105.40%	-89.70%	-171.60%	-1112.50%	-174.00%	-192.00%
Return on Assets (ROA)	-87.00%	-76.20%	-120.80%	-202.20%	-88.50%	-136.60%
Return on Capital (ROIC)	-138.71%	-111.88%	-122.03%	-553.33%	61.24%	-155.83%
Earnings Yield	-317.62%	-226.48%	-181.48%	-150.83%	-67.82%	-218.18%
FCF Yield	-253.74%	-204.80%	-166.78%	-83.72%	-31.37%	-189.55%
Buyback Yield / Dilution	-166.99%	-677.03%	-370.85%	-236.96%	-657.99%	-236.55%
Total Shareholder Return	-166.99%	-677.03%	-370.85%	-236.96%	-657.99%	-236.55%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).